Farallon Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $188M | Buy |
|
|||||
|
2024
Q1 | $98.9M | Sell |
|
|||||
|
2023
Q4 | $258M | Sell |
|
|||||
|
2023
Q3 | $410M | Hold |
|
|||||
|
2023
Q2 | $434M | Buy |
|
|||||
|
2023
Q1 | $407M | Sell |
|
|||||
|
2022
Q4 | $398M | Buy |
|
|||||
|
2022
Q3 | $306M | Buy |
|
|||||
|
2022
Q2 | $306M | Buy |
|
|||||
|
2022
Q1 | $237M | Buy |
|
|||||
|
2021
Q4 | $111M | Buy |
|
|||||
|
2021
Q3 | $20.1M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $106M | Sell |
|
|||||
|
2019
Q2 | $169M | Buy |
|
|||||
|
2019
Q1 | $157M | Hold |
|
|||||
|
2018
Q4 | $148M | Buy |
|
|||||
|
2018
Q3 | $135M | Sell |
|
|||||
|
2018
Q2 | $135M | Buy |
|
|||||
|
2018
Q1 | $125M | Sell |
|
|||||
|
2017
Q4 | $131M | Buy |
|
|||||
|
2017
Q3 | $108M | Buy |
|
|||||
|
2017
Q2 | $19.6M | Sell |
|
|||||
|
2017
Q1 | $35.9M | Buy |
|
|||||
|
2016
Q4 | $9.97M | Buy |
|